| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 546124000 | Tropanes (including nor and dehydro forms) | 12 |
| 20110190503 | Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase - Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amine compounds are described, which are useful as LTA4 hydrolase (LTA4H) modulators. Such compounds may be used in pharmaceutical compositions and methods for modulation of LTA4H and for the treatment of disease states, disorders, and conditions mediated by LTA4 hydrolase activity. | 08-04-2011 |
| 546125000 | Additional hetero ring containing | 4 |
| 20100152450 | NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF - The invention relates to pyridinyl nicotinic acetylcholine receptor ligands, compositions comprising an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand and methods to treat or prevent a condition, such as depression and nicotine dependence, comprising administering to an animal in need thereof an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand. | 06-17-2010 |
| 20130211091 | CRYSTALLINE FORMS OF MARAVIROC PHOSPHATE AND PROCESS FOR MARAVIROC AMORPHOUS FORM - The present invention provides novel crystalline forms of maraviroc phosphate, processes for their preparation and pharmaceutical compositions comprising them. The present invention also provides novel process for the preparation of maraviroc amorphous form and pharmaceutical composition comprising it. | 08-15-2013 |
| 546126000 | Additional polycyclo ring system having the additional hetero ring as one of the cyclos | 2 |
| 20100217002 | NOVEL CHROMEN-2-ONE DERIVATIVES - This invention relates to novel chromen-2-one derivatives useful as starting material for synthesis of pharmaceuticals. | 08-26-2010 |
| 20130137873 | Polycyclo Dyes and Use Thereof - The invention relates to a family of fluorescent compounds that comprise a bridged polycyclo moiety. The compounds can be chemically linked to biomolecules, such as proteins, nucleic acids, and therapeutic small molecules. The compounds can be used for imaging in a variety of medical, biological and diagnostic applications, and are particularly useful for the in vivo imaging of regions of interest within a mammal. | 05-30-2013 |
| 546127000 | Chalcogen bonded directly to ring carbon of the tropane ring system | 3 |
| 546128000 | Polycyclo-carbocyclic ring system | 3 |
| 20090149655 | Process for the preparation of Retapamulin and its intermediates - Processes for preparing tropine derivatives of the following Formula B | 06-11-2009 |
| 20090234125 | Amorphous retapamulin and processes for preparation thereof - An amorphous form of Retapamulin, preferably in powder form, and processes for preparation thereof, are provided. Amorphous Retapamulin of the present invention can contain less than about 10 percent crystallinity, preferably less than about 5 percent crystallinity. Pharmaceutical compositions comprising amorphous Retapamulin are also provided. | 09-17-2009 |
| 20100184987 | Preparation of Retapamulin via its Pleuromutilin-thiol precursor - Provided are processes for preparation of Retapamulin via its pleuromutilin-thiol precursor. | 07-22-2010 |
| 546132000 | Having -C(=X)-, wherein X is chalcogen, bonded directly to the tropane ring system | 4 |
| 20100331544 | METHOD FOR PRODUCING (1R,5S) ANHYDROECGONINE ESTER SALTS - The invention relates to a large-scale method for producing salts of (IR,5S) anhydroecgonine esters. The salt formation and selective crystallization of (IR,5S) anhydroecgonine esters with chiral acids is highly efficient in producing an enantiomer form, any undesired enantiomers and other impurities being removed. The ester and its salts are used as the starting material for producing active agents. | 12-30-2010 |
| 20120203004 | PROCESS FOR THE SYNTHESIS OF ALKYL/ARALKYL (2S)-2-(TERT-BUTOXYCARBONYL)-AMINO-2-[-8-AZABICYCLO[3.2.1]OCT-3-YL]-EXO-A- CETATE AND ANALOGS THEREOF: KEY INTERMEDIATES FOR THE PREPARATION OF DPPIV INHIBITORS - An improved process for the synthesis of intermediates like Alkyl/Aralkyl (2S)-2-(tert-butoxycarbonyl)-amino-2-[-8-azabicyclo[3.2.1]oct-3-yl]-exo-acetate and analogs thereof which are useful in the synthesis of Dipeptidyl peptidase-IV (DP-PIV) inhibitors. | 08-09-2012 |
| 20140235861 | METHOD FOR THE SYNTHESIS OF 18F-LABELLED BIOMOLECULES - The present invention provides a method for the synthesis of | 08-21-2014 |
| 20150038718 | LABELED IODINATED TROPANE FORMULATION - A diagnostic formulation is provided comprising a tropane having a radioactive concentration of at least 1.6 mCi/mL at least about 51 hours post creation. The diagnostic formulation optionally comprises a radiolabeled dopamine transporter (DAT) ligand useful in the diagnosis of Parkinson's disease (PS). One example of a radiolabeled dopamine transporter (DAT) ligand example is [ | 02-05-2015 |
